Clinical & Experimental Cardiology
Open Access
ISSN: 2155-9880
+44 1300 500008
ISSN: 2155-9880
+44 1300 500008
Arati A. Inamdar
Hackensack University Medical Center, USA
Scientific Tracks Abstracts: J Clin Exp Cardiolog
Despite the advancement in medicine, management of heart failure (HF), which usuallypresents as a disease syndrome, has been a challenge to healthcare providers. This is reflected bythe relatively higher rate of readmissions along with increased mortality and morbidity associatedwith HF. In this review article, we first provide a general overview of types of HF pathogenesis anddiagnostic features of HF including the crucial role of exercise in determining the severity of heartfailure, the efficacy of therapeutic strategies and the morbidity/mortality of HF. We then discussthe quality control measures to prevent the growing readmission rates for HF. We also attempt toelucidate published and ongoing clinical trials for HF in an effort to evaluate the standard and noveltherapeutic approaches, including stem cell and gene therapies, to reduce the morbidity and mortality.Finally, we discuss the appropriate utilization/documentation and medical coding based on theseverity of the HF alone and with minor and major co-morbidities. We consider that this reviewprovides an extensive overview of the HF in terms of disease pathophysiology, management anddocumentation for the general readers, as well as for the clinicians/ physicians/hospitalists..
Arati A. Inamdar is a resident Physician at Saint Barnabas Medical Center. She is a director of Research and Development at Saiseva Biotech and Research Scientist in the Hackensack University Medical Center. She is also the Genomics and Biomarkers Programer, at John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.